NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome
|
|
- Amos Joseph
- 5 years ago
- Views:
Transcription
1 NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School of Medicine, New Orleans, LA
2 Disclosure I have no financial disclosures or conflicts of interest.
3 Objectives Review how the diagnosis of NOWS is made, recommended care of the withdrawing infant, and long-term consequences of prenatal drug exposure. Discuss gaps in identifying infants at risk of NOWS, including barriers to maternal disclosure of drug use. Review systems-based approaches to caring for NOWS infants and their caregivers
4 What is NOWS? Neonatal Opiate Withdrawal Syndrome Previously more commonly referred to as Neonatal Abstinence Syndrome (NAS) Clinical symptoms consistent with an infant s withdrawal from opiate exposure in utero Neurological Gastrointestinal Cardiovascular/Respiratory
5 Cost of NOWS CDC estimates that in 2012, the U.S. spent $1.2 billion caring for infants with NOWS Mean length of stay = 16.9 days Estimated cost per infant = $66,700 Infants per year in U.S. = 5.8 per 1000 births Louisiana rates are almost double national average
6 NOWS in the News
7 How Do Moms and Babies Get Screened? Screening for Mothers American Academy of Pediatrics (AAP) and American College of Obstetrics and Gynecology (ACOG) recommend screening all mothers for substance use at each prenatal visit Using a verbal screening tool
8 How Do Moms and Babies Get Screened? Screening for Mothers Use of biological screening methods (i.e. urine, hair) is up to the discretion of the provider Screening for Infants Urine/meconium studies to test for substances Newer testing i.e. umbilical cord but less widely used NO FEDERAL GUIDELINES PROVIDE CRITERIA FOR ASSESSING SUBSTANCE USE IN PREGNANT WOMEN OR IDENTIFYING THEIR AT-RISK INFANTS Variations in practices among OB/GYNs Variations in hospital-based screening Variations in how infants are screening
9 The Argument for Universal Biological Screening 2956 moms 5.4% urine tox screens were positive (n= 159) 3.2% of total were positive for opiates (n=96) 20% of these were in mothers without screening risk factors (representing 19 of 96 +opiate screens) 37% of these required NICU admission for pharmacological tx for withdrawal (representing 7 of 19 infants) The equaled about $500,000 in healthcare expenses in an 18-month period For infants born to mothers without risk factors
10 Limitations to Biologics Maternal & Infant Urine Toxicology False positives, false negatives Inaccurate and inconsistent Infant Meconium Takes longer to result 7 days at our facility More widely used as a confirmatory test Umbilical Cord Testing Growing literature base, but inconsistent literature Not available at all institutions
11 How about Louisiana?
12
13 Louisiana Substance Use in Pregnancy Toolkit Algorithms for how to screen Dialogue scripts for providers Tips for motivational interviewing Open ended questions, reflective listening, etc. How to refer & statewide resources Treatment programs, Other substances tobacco, alcohol Infectious diseases hep B, hep C, HIV
14 Perinatal Commission Sampled a subgroup of birthing hospitals across the state 26 responded Louisiana hospitals : NEITHER Use evidence based verbal screens to universally screen for substance use among women during pregnancy NOR do they universally perform urine drug screens on pregnant women who present to labor and delivery. Several hospitals reported conducting urine drug screens upon hospital admission for pregnant women when there was a concern for substance use
15 What Happens to the Baby in the Hospital? Finnegan Scoring Evaluation tool based on 31 clinical signs of withdrawal Scored by trained providers Consistent elevated scores (>8) prompts further treatment/monitoring Newer Models Eat, Sleep, Console Shorter stays
16 What Happens if the Infant Shows Significant Withdrawal? Infant is monitored & scored for withdrawal symptoms In the Newborn Nursery If Infants scores increase, sent to NICU for treatment Transferred to NICU Infants are weaned from medications and prepared to go home In the NICU
17 When Do We Notify DCFS? Federal Child Abuse Prevention and Treatment Act (CAPTA) designates that mandated reporters must report families to DCFS to be investigated for prenatal neglect when a child 30 days or younger has withdrawal symptoms, a positive screen or observable harmful effects in physical appearance or functioning and the mother unlawfully used (or in a manner not prescribed) a controlled dangerous substance.
18 LA Recommendations for Reporting to DCFS Prenatal neglect means exposure to chronic or severe use of alcohol or the unlawful use of any controlled dangerous substance, as defined by R.S. 40:961 et seq., or in a manner not lawfully prescribed, which results in symptoms of withdrawal in the newborn or the presence of a controlled substance or a metabolite thereof in his body, blood, urine or meconium that is not the result of medical treatment, or observable and harmful effects in his physical appearance or functioning.
19 Can t You Predict Who Will Withdraw? We don t fully understand how opiates cross the placenta or the full on impact of exposure Boys more likely withdraw and we don t know why Drugs have varying half-lives which makes predicting time to peak withdrawal tricky at best Heroin 30 minutes Buprenorphine 69 hours
20 Opiates & NOWS Drug Half-Life (PO) Incidence of NOWS Time to Onset of NOWS sx Time to peak withdrawal Duration of withdrawal Buprenorphin e hours 7-67% hours 72 hours > 28 days Buprenorphin e/naloxone hours/ 2-12 hours 40% hours 72 hours > 28 days Methadone 9-87 hours 13-94% hours hours > 30 days Heroin < 30 minutes 18-80% 8-48 hours hours 8-10 days Hydrocodone 4 hours 5-20% 8-12 hours hours days Oxycodone 3-5 hours 5-20% 8-12 hours hours days Morphine 2-4 hours 5-20% 8-12 hours hours days
21 What Are the Long Term Consequences? Neurodevelopmental Complicated due to impact of caregiving environment Long term perception of pain in exposed infants? Otherwise, we don t really know Very limited studies have been done Very limited sample size typically only a few dozen infants per study Inconsistent treatment regimens add an extra variable
22 So What Barriers Exist to Identifying These Babies? Since 1991, Louisiana Medicaid has prohibited reimbursement for the use of narcotics including methadone in the treatment of substance use disorders Anecdotal Reports: Addiction treatment providers dismiss pregnant patients from their care for fear of liability and concern for poor outcomes Conflicting thoughts on best route to take prenatally Rapid detox Continued maintenance
23 Maternal Considerations What s going on in the brain of mothers addicted to opiates? Difficult to watch infant s withdrawal Maternal guilt, anxiety about her ability to parent Secondary blame (partners, family, healthcare) Responding to infant s cues Based on mom s working mental models BUT Maternal brain plasticity
24 How do these babies make you feel?
25 How do these babies make you feel?
26 Doesn t Breastmilk Fix Everything? Data estimates that only about 25% of eligible mothers breastfeed to some extent Average duration = just under 6 days Methadone & buprenorphine both compatible with breastfeeding
27 Breastfeeding and NOWS Primarily breastmilk v. primary formula resulted in: Later onset of NAS (10 days v. 3 days) Required opiate treatment less often (53% v. 79%) Shorter LOS (15 days v. 19 days) Mothers who breastfed infants for 72 hours reduced odds that infant would require opiate treatment by half
28 Breastfeeding and NOWS Breastfeeding has been associated with: Reduced severity Delayed onset Decreased need for opiates Benefits also seen when mothers room in with babies 79% decrease in need for treatment for NOWS
29 So what s a pediatrician to do? Lack of comprehensive centers taking the lead on following these children, ensuring families are accessing services (i.e. Early Steps) and limited attention is paid to ensuring to supporting positive parent-child interactions
30 Final Thoughts Maternal substance use and subsequent infant opiate withdrawal is a complex physiological and social interplay that needs compassionate, evidence-based systematic approaches to ensure proper care of the maternal-infant dyad Ideal care should be based on centers of excellence dedicated to streamlining continuity of care and providing the absolute best treatment for moms and their babies
31 Opportunities Prenatal Improved access to perinatal providers comfortable with and capable of treating maternal opiate dependence throughout the spectrum of pregnancy Postnatal Enhanced breastfeeding education and support for mothers with opiate use
32 Opportunities Logistical Comprehensive centers of excellence to promote smooth prenatal to perinatal to neonatal transition for infants exposed to intra-uterine opiates and their mothers Academic Increased research into additional modalities, including psychosocial interventions, to help decrease costs and facilitate smooth transitions
33 Thank you!
34 Questions or Comments for the Group?
35 References Ko JY et al. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. Morbidity and Mortality Weekly Report, 66(9): March 10, Wexelblatt SL et al. Universal Maternal Drug Testing in a High Prevalance Region of Prescription Opiate Abuse. J Peds 2015 Oct;166(3): s/223_response%20to%20house%20concurrent%20resolution%20162-final %20(3).pdf s/223_response%20to%20house%20concurrent%20resolution%20162-final %20(3).pdf s/223_response%20to%20house%20concurrent%20resolution%20162-final %20(3).pdf
36 References Velez M et al.the opioid dependent mother and newborn dyad: nonpharmacological care. J Addict Med Sep 1;2(3): egulations/223_response%20to%20house%20concurrent%20resolutio n%20162-final %20(3).pdf Wachman EM et al. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med 2010 Aug;5(4): Holmes AP et al. Breastfeeding considerations for mothers of infants with neonatal abstinence syndrome. Pharmacotherapy Jul;37(7): Abdel-Latif ME et al. Effects of Breast Milk on the Severity and Outcome of Neonatal Abstinence Syndrome among Infants of Drug-Dependent Mothers. Pediatrics 2006;117(6) McQueen KA et al. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care. 2011;11(4):
Opioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationObjectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016
Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationJohann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works
From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a
More informationOpioids in Pregnancy. Beyond to Baby GENERAL INFO
Opioids in Pregnancy and Beyond to Baby by Marcia W. VanVleet, MD, MPH Medical Director, Newborn Service Team, Women and Infants Hospital, and Assistant Professor of Pediatrics, Brown Alpert Medical School,
More informationDisclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond
Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to
More informationOpioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome
Opioid Use Disorder in Pregnancy Neonatal Abstinence Syndrome Opioid Use Disorder and Pregnancy Cont. 4.6 million women (or 3.8 percent) ages 18 and older misused prescription drugs in 2013. One-third
More informationEAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates
EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates NICOLE DUNCAN BSN, RN, CPN MAY 2018 Pediatric Educator, MultiCare Health System DISCLAIMER I have
More informationNeonatal Abstinence: The epidemic Its Impact on All of Us
Neonatal Abstinence: The epidemic Its Impact on All of Us Michelle Bode MD, MPH Neonatologist Crouse Hospital Assistant Professor Pediatrics SUNY Upstate Objectives & Disclosure Statement 1) The participant
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationMaternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home
More informationCare of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?
Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationOutcomes of Infants with Neonatal Abstinence Syndrome
Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida
More informationRunning head: NEONATAL ABSTINENCE SYNDROME 1
Running head: NEONATAL ABSTINENCE SYNDROME 1 Nursing Treatment of Neonatal Abstinence Syndrome Ferris State University Kelly Geraghty, Tracy James, Kristen Lintjer, Sara Potes, Rikki Zissler NEONATAL ABSTINENCE
More informationLearning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons
Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes
More informationSupersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required
Effective Date 12/13/16 Neonatal Abstinence Syndrome (NAS) Date Approved 12/13/16 Guideline Pharmacologic Protocol Supersedes Date None and Management Guidelines Originating Dept. NICU Document Owner Dir.,
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More informationAdvancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance
Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical
More informationNeonatal Abstinence Syndrome (NAS)
Neonatal Abstinence Syndrome (NAS) Jodi Jackson, MD Neonatologist Children's Mercy Hospital Associate Professor of Pediatrics University of Missouri-Kansas City School of Medicine Medical director NICU
More information2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society
Pregnant Women Who Use Drugs: Stigma, Science and Society Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationMaternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health
Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health Columbus, Ohio Assignment Description The rapid advance of the opiate crisis has had far
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationIDENTIFICATION AND MANAGEMENT OF PERINATAL SUBSTANCE ABUSE
IDENTIFICATION AND MANAGEMENT OF PERINATAL SUBSTANCE ABUSE Carol Wallman DNP-c, NNP-BC Neonatal Nurse Practitioner Coordinator Neonatal Nurse Practitioner Education Children's Hospital Colorado Affiliate
More informationAddiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018
Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Fear Shame Commitment Barriers Opportunities Fear Thalidomide induced phocomelia 1957 Fear Fetal Alcohol
More informationNeonatal abstinence syndrome
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on the Neonatal Abstinence Syndrome. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationNeonatal Abstinence Syndrome
5 Neonatal Abstinence Syndrome Amy P. Holmes, PharmD Introduction Neonatal abstinence syndrome (NAS) is recognized as the effect of intrauterine exposure to substances that can cause physical dependence.
More information8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY
ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance
More informationMedication for the Treatment of Addiction (MAT)
Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication
More informationClinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP
Clinical Management of Neonatal Abstinence Syndrome Tricia L. Romesberg, DNP, MSN, ARNP, CNNP Timeline Incidence of NAS Healthcare Cost and Utilization Project (HCUP), 1999-2013 State Inpatient Databases
More information9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment
Postpartum Counseling for Women in MAT Katie Clark MSPH, CSAC A little about Katie SUD and PH crossroads BA Health Arts and Sciences Goddard College MSPH MCH UNC Project Lazarus, Yale, CHER Solutions LLC
More informationSubstance-Exposed Newborns
Substance-Exposed Newborns State of Oklahoma 2017 Substance-Exposed Newborns State of Oklahoma 2017 Legal Background Oklahoma statute, Title 63, 1-550.3, states, "The Department of Human Services shall
More informationOpiate Use in Reproductive Age Females
Opiate Use in Reproductive Age Females February 15, 2017 2:00 pm-3:00 pm ET In order to hear the presentation please call +1 (562) 247-8422, access code 579-542-512 All Participant Phone Lines are Muted
More informationMedication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers
Medication-Assisted Treatment & Pregnancy Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers Addiction/ Substance Use Disorder Addiction is a Biopsychosocial Disease Has
More information2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem
Substance Use Disorders Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Department of Behavioral Medicine and Psychiatry, WVU Celebrating Connections Conference - April 2017 Substance Use Disorders
More informationTalking with your doctor
SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may
More informationLori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center
Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center NSDUH, 2012 National Survey on Drug Use and Health: 2012 Substance abuse: Public Health Problem
More informationOhio Perinatal Quality Collaborative
Ohio Perinatal Quality Collaborative Neonatal Abstinence Syndrome Project Presented by Michele Walsh MD Neonatal Lead Physician December 2017 Disclosure I have no financial or other conflicts of interest.
More informationEffective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.
Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription
More informationAddressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges
Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges Three Branch Institute on Child Well-Being July 1, 2014 Sid Gardner, MPA Drugs of the Decades
More informationMethadone and Pregnancy
Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine
More informationDevelopment and use of the Eating, Sleeping, Consoling (ESC) Care. for opioid-exposed newborns and their families in Northern New England
Development and use of the Eating, Sleeping, Consoling (ESC) Care Tool to promote healthy beginnings for opioid-exposed newborns and their families in Northern New England Bonny Whalen, MD Oct 5, 2018
More informationKRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH
KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction
More informationThe Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy
The Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy Janice Lyu, MS Senior Hepatitis B Program Associate Charles B. Wang Community Health Center (CBWCHC) Charles B Wang
More informationOpioid Abuse Treatment in Pregnancy
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works
More informationNeonatal Abstinence Syndrome
Neonatal Abstinence Syndrome TAMARA HARVANKO RN, BAN HIGH RISK OB CARE COORDINATOR CASE MANAGEMENT HENNEPIN COUNTY MEDICAL CENTER TAMARA.HARVANKO@HCMED.ORG 612-873-6552 https://www.youtube.com/watch?v=tk2hoyupkvi
More informationADDICTION IN PREGNANCY
ADDICTION IN PREGNANCY R. Corey Waller MD, MS, DFASAM Sr. Medical Director, Education and Policy The National Center for Complex Health and Social Needs DISCLOSURES No relevant disclosures OBJECTIVES The
More informationMultidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population
Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Dale Robinson MD,FACOG Jennifer Gonzalez RN,BSN Surgeon General s Report 2016 Office
More informationSubstance-Exposed Newborns
Substance-Exposed Newborns State of Oklahoma 2016 Substance-Exposed Newborns State of Oklahoma 2016 Legal Background Federal guidelines in the Child Abuse Prevention and Treatment Act (CAPTA) require states
More information... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot
Department of... Health Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN Overview and Regional Snapshot Cynthia C. Thomas, DO, MPH, Assistant Health Officer, Northeast Regional Health
More informationAddressing Substance Use Among Pregnant Women and New Moms
ADRIANA KOHLER AND KATE MURPHY SENIOR POLICY ASSOCIATES AKOHLER@TXCHILDREN.ORG KMUPRHY@TXCHILDREN.ORG MARCH 20, 2018 Addressing Substance Use Among Pregnant Women and New Moms Opportunities to Improve
More informationAnesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a
Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a
More informationNEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE
NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of
More informationSubstance-Exposed Newborn
Substance-Exposed Newborn Definition: Substance-exposed newborn as a maltreatment occurs when a child is exposed to a controlled substance or alcohol prenatally. Exposure to a controlled substance or alcohol
More informationPregnancy, Opioid Addiction, and Care Issues in Virginia
Pregnancy, Opioid Addiction, and Care Issues in Virginia Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationNeurodevelopmental Risk?
Normal Newborn During transitional hypoglycemia normal newborns have an enhanced ketogenic response to fasting. Newborn brains have enhanced capability to use ketone bodies for fuel Allows newborns to
More information5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead
Maria H. Elswick, MD Maternal Wellness Program - Physician Lead Department of Obstetrics & Gynecology Kaiser Permanente San Diego Maria H. Elswick, MD Maternal Wellness Program Physician Lead Department
More informationThe Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome
Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/
More informationOpioid Use Disorder. in Pregnancy: Care and Context of Mother and Newborn
Opioid Use Disorder in Pregnancy: Care and Context of Mother and Newborn PRESENTED BY: Mishka Terplan MD MPH FACOG FASAM Kelley Saia MD FACOG DABAM Elizabeth Krans MD MSc FACOG September, 22 2016 Medicaid
More informationThe Scoop on Biological Testing for Detecting or Confirming Drug-Exposed Newborns What, When and How?
The Scoop on Biological Testing for Detecting or Confirming Drug-Exposed Newborns What, When and How? Gwen McMillin, PhD, DABCC University of Utah, ARUP Laboratories Objectives Compare and contrast approaches
More informationEmerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer
Emerging Populations: Challenges for the Early Childhood System Presented by Maureen Greer Early Intervention/Early Childhood Special Interest Group (EIEC SIG) Webinar Series September 26, 2017 Presenter
More informationUnderstanding Prenatal Drug Exposure
Understanding Prenatal Drug Exposure Prenatal Drug Exposure A mother s drug use hurts her unborn baby. Slide 2 Drug Categories Part 1 Prescription drugs: Prescribed by a doctor and used under a health
More informationNeonatal Drug Withdrawal
History Neonatal Drug Withdrawal Katherine Wang, MD, FAAP Avera McKennan Children s Hospital NICU Morphine has been used for pain for many years Congenital morphinism was not recognized as an entity until
More informationClinical Policy: Neonatal Abstinence Syndrome Guidelines Reference Number: CP.MP.86 Effective Date: 10/13
Clinical Policy: Reference Number: CP.MP.86 Effective Date: 10/13 Last Review Date: 10/17 See Important Reminder at the end of this policy for important regulatory and legal information. Revision Log Description
More informationWomen in the Opioid Crisis: Pain, Pregnancy and Life Course
Women in the Opioid Crisis: Pain, Pregnancy and Life Course Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics & Gynecology and Psychiatry Virginia Commonwealth University Addiction Medicine
More informationTorri Metz, MD Maternal-Fetal Medicine December 15, 2017
Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 I have no relevant financial relationships to disclose or conflicts of interest to resolve. Describe public health impact of expanding marijuana
More informationTexas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome
Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome 1 Learning Objectives Become familiar with how the opioid epidemic is impacting Texas women Become familiar with Neonatal
More informationTHE OPIOID DEPENDENT MOTHER AND NEWBORN - AN UPDATE
THE OPIOID DEPENDENT MOTHER AND NEWBORN - AN UPDATE THE 6 TH ANNUAL IVEY SYMPOSIUM Ron Abrahams, Claudette Chase, Judy Desmoulin, Mel Kahan, David Knoppert, Gideon Koren, Laura Lyons, Alice Ordean, Henry
More information8/27/2018. Katie Brooks, DO, FAAP CHI Health St. Elizabeth. I have nothing to disclose
Katie Brooks, DO, FAAP CHI Health St. Elizabeth I have nothing to disclose 1 Briefly review the history of NAS and current prevalence Understand definition of NAS and which motherbaby dyads should be screened
More informationSUBSTANCE EXPOSED NEWBORNS
Substance Exposed Newborns 1 SUBSTANCE EXPOSED NEWBORNS STATE OF OKLAHOMA 2012 2 Substance Exposed Newborns The mission of the Oklahoma Department of Human Services is to help individuals and families
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationNeonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey
RESEARCH ARTICLE Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey AUTHORS Aakriti Mehta, BA, 1 Kathryn Dawn Forbes, MD, MS,
More informationThe Substance Exposed Newborn Alphabet Soup
The Substance Exposed Newborn Alphabet Soup SEN, NAS, NOWS, OUD, SUD & MAT Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017
More informationBeyond Birth: A Comprehensive Recovery Center serving parenting women
Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The
More informationProduct Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD
1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits
More informationOpioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard
Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among
More informationContinuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment
Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment This webinar will be recorded and available on the NPIC/QAS website www.npic.org. Nurse Planner:
More informationNon-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS)
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2014 Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS) Michael
More informationFunding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists
A training offered by Dr. Beth Bailey, Associate Professor of Family Medicine, East Tennessee State University; and by the Tennessee Intervention for Pregnant Smokers (TIPS) Program Funding for TIPS provided
More informationThe Impact of Neonatal Abstinence Syndrome: The View from a Rural Kentucky Hospital
Volume 3 Issue 3 Article 10 2017 The Impact of Neonatal Abstinence Syndrome: The View from a Rural Kentucky Hospital Sydni Fazenbaker Crowell, Allison M. Crump-Rogers, William Crump, and LeAnn Langston
More informationNEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18
NEONATAL ABSTINENCE SYNDROME NAS Kickoff 11/8/18 OPIOID EPIDEMIC STATISTICS USA is 4.6% of the world s population 78 Americans die every day from opioid overdoses 66% of all illegal drug use 80% of global
More informationNeonatal Abstinence Syndrome:
Neonatal Abstinence Syndrome: Reconsidering the Standard Approach Matthew Grossman, M.D. Assistant Professor of Pediatrics Yale School of Medicine Quality and Safety Officer Yale-New Haven Children s Hospital
More informationEI Leadership April 24, 2018
Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families
More informationMOMS Project Panel Overview
MOMS Project Panel Overview Rick Massatti, PhD, Ohio Department of Mental Health and Addiction Services Jennifer Bailit, MD, MetroHealth Medical Center Mike Marcotte, MD, Tri-Health Mona Prasad, DO,MPH,
More informationA New approach to NAS: home in 6 days
+ A New approach to NAS: home in 6 days Lisa Grisham, NNP-BC Moe Kane, NNP-BC Banner University Medical Center - Tucson University of Arizona, College of Medicine Department of Pediatrics Division of Neonatology
More informationObjectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?
Objectives At the end of the lesson participants will be able to: Identify the types of HIV tests available in Botswana State who should be tested Identify which tests are used for infants and children
More informationPROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3
PROJECT DOVE Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3 Partners Support Bureau of Justice Assistance, Department of Justice Grant # PM-BX-Koo4 Treatment Plan MODULE
More informationMarijuana in the Obstetric Population
Marijuana in the Obstetric Population Brittany MacGregor PGY 1 on behalf of Sophia Lenson PGY 3, Queens OB/Gyn Objectives 1. Review the status of legalization of cannabis products in Canada and the potential
More informationHow long does codeine stay in breast milk
How long does codeine stay in breast milk 2-4-2009 How long does t3's with codeine stay in my system after withholding breast feeding and infants exposed to codeine in milk. Once you have decided to stop
More informationTestimony of Debra L. Bogen, MD, F AAP, F ABM
One Children's Hospital Drive 4401 Penn Avenue Pittsburgh, PA 15224 www.chp.edu Testimony of Debra L. Bogen, MD, F AAP, F ABM To The PA House, Children and Youth Committee Regarding Public Hearing on the
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationAn Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women
An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns
More informationNeonatal Abstinence Syndrome:
Neonatal Abstinence Syndrome: Rethinking Our Approach Matthew Grossman, M.D. Assistant Professor of Pediatrics Yale School of Medicine Quality and Safety Officer Yale-New Haven Children s Hospital Patrick,
More informationPostpartum Depression Screening
Postpartum Depression Screening October 13, 2018 Deborah CowleyMD Psychiatrist Perinatal Consultant University of Washington Disclosures Perinatal Psychiatry Consultation Line/PAL for Moms UW Perinatal
More informationChild Welfare and MOMS: Building Partnerships to Improve Care
Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly
More informationMarijuana in Pregnancy
Idaho Perinatal Project 2019 Winter Conference Marijuana in Pregnancy What are we telling our patients? Stacy T. Seyb, MD Kristy Schmidt, MN, RN, NEA-BC Special Thanks to Tori Metz, MD University of Utah
More information1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT
PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES Susan Kilman LCSW, AADC THE PROBLEM ABOUT 1 IN 8 (8.7 MILLION) AGED 17 OR YOUNGER LIVE IN HOUSEHOLDS WITH AT LEAST ONE PARENT WHO HAD
More informationImpact of Parental Presence at Infants Bedside on Neonatal Abstinence Syndrome
RESEARCH ARTICLE Impact of Parental Presence at Infants Bedside on Neonatal Abstinence Syndrome Mary Beth Howard, MD, MSc, a Davida M. Schiff, MD, b Nicole Penwill, BA, c Wendy Si, MD, c Anjali Rai, MD,
More information